Novo Nordisk said its new-generation diet drug Cagrisema achieved an average weight loss of 25% among obese or overweight adult women.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.